Navigation Links
SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS
Date:2/9/2010

MUMBAI, India, Feb. 9 /PRNewswire/ -- SIRO Clinpharm, a Contract Research Organization (CRO) with a presence in India, Western and Central Eastern Europe, and the United States today announced its alliance with DreamCIS Inc., a leading CRO based in Seoul, South Korea.  

DreamCIS has nearly a decade of experience in offering clinical research services to pharmaceutical companies, bio venture companies, medical device manufacturers, and functional food producers. Their services includes Clinical Trial Management, Pharmacovigilance, Post Marketing Surveillance (PMS), Data Management, Biostatistics and Quality Assurance services.

SIRO Clinpharm has been in the arena of contract clinical research for more than 14 years, conducting ICH GCP compliant clinical trials for its global clientele. In addition to the services that DreamCIS provides, SIRO's service list also includes Medical Writing, Clinical Trials Supplies Management, Feasibility and Patient Planning.

"This pact will help us on one hand to build a strong competitive advantage in the Asia Pacific region, while on the other hand it will create a sustainable value for our existing as well as potential customers," said Ajit Nair, Ph.D., President, India. He further added that, "Our goal is to offer a wider platform of patient recruitment capabilities from the Asia Pac region for our global client base."

"We are one of the leading and fastest growing CROs in South Korea. However, looking at the increasing number of global clinical trials and the rapid growth in the Asian clinical trials market, we were looking at associating ourselves with a CRO having a global exposure; not only from business vertical perspective but also from the perspective of moving up on the learning curve. I think our mutually beneficial alliance with SIRO is a definite step in this direction," said Won-Jung Choi, President, DreamCIS Inc.    

"Korea is a rapidly growing clinical trials market due to various advantages it offers like pre-approved and well-equipped clinical trial sites, trained professionals, and transparent and efficient regulatory processes," said Chetan Tamhankar, PhD, SIRO's Chief Executive Officer. "We are confident this alliance will be of immense value to SIRO and widen our global service capabilities."

About SIRO:

SIRO Clinpharm Private Limited (SIRO) is among one of the leading global Clinical Research Organizations (CROs), offering full scope services, conducting clinical trials in the pharmaceutical, biotechnology and medical devices sectors in compliance with international standards. SIRO is one of the first CROs founded in India, which caters to the needs of pharmaceutical companies across the world. The company has offices in India, the USA, Israel and in Europe in Germany, Romania, Estonia, Greece, Czech Republic and Spain.

For more information please visit - www.siroclinpharm.com

About DreamCIS:

Founded in April, 2000, DreamCIS has been dedicated to providing a full range of clinical services for pharmaceutical companies, bio venture companies medical device manufacturers and functional food producers in Korea. The company has also undertaken projects for some of the top global pharmaceutical companies in a broad range of therapeutic areas in accordance with ICH GCP guidelines.

For more information please visit – www.dreamcis.com

SOURCE SIRO Clinpharm

RELATED LINKS
http://www.siroclinpharm.com

'/>"/>

SOURCE SIRO Clinpharm
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SIRO Clinpharm Collaborates with Mediscis, Broadens Early Phase Drug Development Expertise
2. DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm
3. SIRO Clinpharm and CambReg Ltd Strategic Alliance to Offer Regulatory Services in Europe
4. SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
5. VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms From Bayer Schering Pharma
6. JDRF Forms Partnership With Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes
7. Zassi Medical Evolutions Spins out Electrical Stimulation Technology for Gastrointestinal Continence Control and Forms New Company with Technology Investment Firm
8. Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group
9. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
10. Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
11. CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL ) today announced ... Raymond James and Associates, 38 th ... in Orlando, FL. Cowen and ... on March 7, 2017 in Boston, MA. ... 2017 in Miami, FL. ...
(Date:2/27/2017)... Leading Countries, Technologies and Companies The ... a CAGR of 8.9% from 2016-2021 and CAGR of 9.2% from ... 9.1% from 2016 to 2027. The market is estimated at $816m ... ... on to discover how you can exploit the future business opportunities ...
(Date:2/27/2017)... October – December 2016 Revenues amounted to SEK 0.3 ... Result after tax amounted to SEK -16.3 (-6.5) million, corresponding ... Cash flow from operating activities amounted to SEK -8.3 (-7.3) million ... Period full year 2016 ... amounted to SEK -39.5 (-29.5) million Result after tax amounted ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, ... announce an upgrade to the company's Yelp listing. Bay Area residents struggling from ... diverse as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular ...
(Date:2/26/2017)... ... February 26, 2017 , ... Today, ... the 7th Edition of International Social Design Awards. , The 7th A' ... System Designers, Governments and Institutions worldwide with realized projects and conceptual works. , ...
(Date:2/26/2017)... New York, New York (PRWEB) , ... February ... ... of luxury baby products for wholesale distribution in North America, today announced it ... established online sites. The company, which prides itself on crafting quality and unique ...
(Date:2/26/2017)... ... ... ODH, Inc.™ announced today it will exhibit and speak at the ... in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present on ... health management. , ODH will also have an exhibit booth where attendees may speak ...
(Date:2/25/2017)... ... ... FCPX users now have the ability to sharpen a desired color range ... have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, vertical sharpening, and ... can visually see the color range effected with ease all within Final Cut ...
Breaking Medicine News(10 mins):